ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity.
Julia PohlRaluca-Ileana MincuSimone M MrotzekReza WakiliAmir Abbas MahabadiSophia K PotthoffJens Thomas SivekeUlrich Bernd KellerUlf LandmesserTienush RassafMarkus S AnkerMatthias TotzeckPublished in: Cancers (2021)
ECG scoring prior to the start of anti-cancer therapies may help to identify therapy-naïve cancer patients at a higher risk for the development of cardiotoxicity.